The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Management of Hepatitis C in Children and Adolescents
J Pediatric Infect Dis Soc. 2020 Oct 12;piaa114. doi: 10.1093/jpids/piaa114. Online ahead of print.
Victoria A Statler1, Claudia Espinosa2
Author information
1Department of Pediatrics, University of Louisville, Louisville, USA.
2Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, USA.
Abstract
The management of hepatitis C virus (HCV) infections has changed dramatically in recent years with the use of direct antiviral agents (AADs). New AADs have excellent safety profile and demonstrated to be highly effective. Interferon free regimens are now recommended for children and adolescents but significant barriers for treatment exist. Overcoming those barriers will facilitate HCV elimination. This review covers varied topics to familiarize providers with the current status of pediatric HCV management in light of newly available DAAs medications.